Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06565052

The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial

Led by Dana-Farber Cancer Institute · Updated on 2025-11-24

40

Participants Needed

2

Research Sites

137 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to determine the feasibility of a prehabilitation program for participants diagnosed with rectal cancer undergoing neoadjuvant chemotherapy and/or radiation, followed by surgical resection. The names of the groups in this research study are: * Group A: Prehabilitation program * Group B: Usual Care

CONDITIONS

Official Title

The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older at enrollment
  • English-speaking
  • Diagnosis of clinical stage II or III rectal cancer
  • Planned, ongoing, or recently completed neoadjuvant treatment including chemoradiation, total neoadjuvant therapy, or chemotherapy only
  • Able to understand study procedures and provide informed consent
Not Eligible

You will not qualify if you...

  • Known distant metastatic disease at diagnosis
  • Unable to perform exercise testing due to functional incapacity
  • Comorbid conditions or cognitive/physical impairments that contraindicate exercise
  • Currently being treated for a secondary primary tumor in addition to rectal cancer
  • Enrolled in another clinical trial that would prevent participation in this study's tasks
  • Participating in more than 60 minutes of moderate-to-vigorous aerobic exercise per week over the past month

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115

Actively Recruiting

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

J

Jeffrey Meyerhardt, MD, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here